Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

J&J and LDC to join forces on unmet medical needs

Collaboration will aim to find and accelerate new potential treatments

- PMLiVE

Bayer sells diabetes division to Panasonic Healthcare

€1.02bn sale includes Contour electronic meters and other medical devices

- PMLiVE

Praluent and Repatha backed for approval in US

Sanofi and Amgen remain in fierce competition in PCSK9 inhibitors

- PMLiVE

Just manufacturing pills ‘no longer good enough for patients’

Pharma must truly move beyond the pill and embrace digital health, according to industry heads

- PMLiVE

Clark Health Communications make three team additions

Announcements coincides with its Communiqué Awards nominations

- PMLiVE

Patrick Fabbio named CFO at electroCore

He joins from NPS Pharmaceuticals where he was VP finance

- PMLiVE

MRC Technology and Peptinnovate join on bone disease

Firms aim to discovery a therapy using natural peptides 

EISAI

Eisai launches thyroid cancer therapy Lenvima in UK

The UK is its first European market, with wider EU roll out expected in coming months

- PMLiVE

Receptos rejected AZ takeover bid, say sources

Sources also claim the Delaware-based firm is being chased by Gilead Sciences and Teva

- PMLiVE

Four Communications acquires MSA Media

Takeover will create Four MSA

- PMLiVE

Building and retaining great talent

Consultants at Ashfield discuss how to hold on to your best talent

Biomarin

BioMarin files muscular dystrophy drug in EU

Drisapersen could be the first ‘exon-skipping’ therapy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links